CERVICAL NEOPLASMS
Clinical trials for CERVICAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new CERVICAL NEOPLASMS trials appear
Sign up with your email to follow new studies for CERVICAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: CERVICAL NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists track gene therapy patients for 15 years to ensure safety
Knowledge-focused ENROLLING_BY_INVITATIONThis study is not a treatment, but a long-term safety check. It follows people who previously received gene therapy for cancer in other National Cancer Institute studies. Researchers will contact participants yearly for up to 15 years to check for any delayed side effects or heal…
Matched conditions: CERVICAL NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:10 UTC